FIND HF Risk-guided Screening for Heart Failure - Pilot Study
FIND HF
FIND HF: Risk-guided Screening for Heart Failure
2 other identifiers
observational
475
0 countries
N/A
Brief Summary
The goal of this clinical trial is to learn if the FIND HF algorithm detection rates of heart failure during testing are higher amongst participants identified as high FIND-HF risk compared to those identified as low risk in a population identified as at risk of undiagnosed heart failure. The main questions it aims to answer are:
- Are people who are identified as high risk by the FIND-HF tool more likely to be diagnosed with heart problems during testing than those identified as low risk?
- Are people identified as high risk by the FIND-HF tool more likely to show signs of heart problems during testing than those identified as low risk?? Researchers will compare patients in the high risk and low risk groups to see if more patients are detected with asymptomatic heart failure in the high risk group compared to the low risk group. Participants will attend one visit at a local clinic where they will undergo an NT proBNP blood test which indicates heart failure and an echocardiogram to evaluate the heart's chambers, valves and overall function to help diagnose various heart conditions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2026
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 30, 2025
CompletedFirst Posted
Study publicly available on registry
January 26, 2026
CompletedStudy Start
First participant enrolled
February 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 1, 2028
January 26, 2026
January 1, 2026
1.4 years
September 30, 2025
January 19, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To determine whether detection rates of a composite of asymptomatic LVSD, HFrEF, HFmREF, or HFpEF during diagnostics are higher amongst participants identified as high FIND-HF risk compared to those identified as low risk
Odds ratio of asymptomatic LVSD, HFrEF, HFmREF, or HFpEF detection rates from intervention in people identified as high HF risk compared with people identified as low HF risk
Through study completion, an average of 12 months from date of enrolment
Secondary Outcomes (1)
To determine if components of composite outcome during diagnostics are higher amongst participants identified as high FIND-HF risk compared to those identified as low risk
Through study completion, an average of 12 months from date of enrolment
Study Arms (1)
Patients at risk of developing Heart Failure
Patients will attend one visit with a Cardiology specialist Clinical research fellow who will carry out tests to detect Heart Failure
Interventions
Algorithm developed by the research team to identify patients at risk of heart failure that is currently undetected.
Eligibility Criteria
Patients identified at risk of developing Heart Failure by the FIND HF algorithm and are aged 40 and over, living in the Yorkshire area.
You may qualify if:
- Registered with a doctor practice that uses electronic health system to record patient medical notes Age at enrolment greater or equal to 40 Identified as at risk of developing Heart Failure
You may not qualify if:
- Registered with a doctor practice that is participating in research studies relating to heart failure screening
- Known diagnosis of HF
- On the palliative care register
- Unable to give written informed consent for participation in the study
- Unable to adhere to the study requirements
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Chris P. Gale, Yes
University of Leeds
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Cardiovascular Medicine
Study Record Dates
First Submitted
September 30, 2025
First Posted
January 26, 2026
Study Start
February 1, 2026
Primary Completion (Estimated)
July 1, 2027
Study Completion (Estimated)
October 1, 2028
Last Updated
January 26, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share
Planning to commercialise algorithm